Vorinostat Active Not Recruiting Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02412475Epigenetic Reprogramming in Relapse AML